Role of adenosine in the renal responses to contrast medium

Kidney International

Volumn 49, Issue 5, 1996, Pages 1199-1206

  Arakawa, Koki ^a   Suzuki, Hiromichi ^a   Naitoh, Mareo ^a   Matsumoto, Akira ^a   Hayashi, Koichi ^a   Matsuda, Hiroto ^a   Ichihara, Atsuhiro ^a   Kubota, Eiji ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; ADENOSINE; DILTIAZEM; IOHEXOL; NONIONIC CONTRAST MEDIUM; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0029887486     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.173     Document Type: Article

References (12)

1. SCHWAB SJ, HLATKY MA, PIEPER KS, DAVIDSON CI, MORRIS KG, SKELTON TN, BASHORE H: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320:149-153, 1989
2. PARFREY PS, GRIFFITHS SM, BARRETT BJ, PAUL MD, GENGE M, WITHERS J, FARID N, MCMANAMON PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. N Engl J Med 320:143-149, 1989
3. BARRETT BJ, PARFREY PS, VAVASOUR HM, MCDONALD J, KENT G, HEFFERTON D, O'DEA F, STONE E, REDDY R, MCMANAMON PJ: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 41:1274-1279, 1992
4. KARTZBERG RW, SCHULMAN G, MEGGS LG, CALDICOTTA WJH, DAMIANO MM, HOLLENBERG NK: Mechanism of renal response to contrast medium in dogs. Decrease in renal function due to hypertonicity. Invest Radiol 18:74-80, 1983
5. TALNER LB, DAVIDSON AJ: Renal hemodynamic effects of contrast media. Invest Radiol 3:310-317, 1968
6. DERAY G, MARTINEZ F, CACOUB P, BAUMELOU B, BAUMELOU A, JACOBS C: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 10:316-322, 1990
7. AREND LJ, BAKRIS GL, BURNETT JC JR, MEGERIAN C, SPIELMAN WS: Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 110:406-411, 1987
8. ERLEY CM, DUDA SH, SCHLEPCKOW S, KOEHLER J, HUPPERT PE, STROHMAIER WL, BOHLE A, RISLER T, OSSWALD H: Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425-1431, 1994
9. OSSWALD H: Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol 288:79-86, 1975
10. SUZUKI F, SHIMADA J, MIZUMOTO H, KARASAWA A, KUBO K, NONAKA H, ISH A, KAWAKITA T: Adenosine Al antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. J Med Chem 35:3066-3075, 1992
11. MIZUMOTO H, KARASAWA A, KUBO K: Diuretic and renal protective effects of 8-(normantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonists, via pertussis toxin insensitive mechanism. J Pharmacol Exp Ther 266:200-206, 1993
12. CHAI H, BATUMAN V, PUSCHETT DB, PUSCHETT JB: Effect of KW-3902, a novel adenosine A1 receptor antagonist, on sodium-dependent phosphate and glucose transport by the rat renal proximal tubular cell. Life Sci 55:839-845, 1994